US Stock MarketDetailed Quotes
VRAX Virax Biolabs
- 2.0300
- +0.0100+0.50%
Trading Nov 27 13:51 ET
8.81MMarket Cap-777P/E (TTM)
2.1100High1.9700Low35.03KVolume2.0000Open2.0200Pre Close71.58KTurnover0.86%Turnover RatioLossP/E (Static)4.34MShares8.999952wk High1.02P/B8.23MFloat Cap0.600052wk Low--Dividend TTM4.05MShs Float290.0000Historical High--Div YieldTTM6.93%Amplitude0.6000Historical Low2.0430Avg Price1Lot Size
About Virax Biolabs Company
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Company Profile
SymbolVRAX
Company NameVirax Biolabs
Listing DateJul 21, 2022
Issue Price5.00
Founded2013
CEOMr. James Foster
MarketNASDAQ
Employees17
Fiscal Year Ends03-31
AddressBo'Ness Road Newhouse
CityLanarkshire
ProvinceScotland
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 5UH
Phone44-20-7788-7414
Websitehttp://www.viraxbiolabs.com
Company Executives
- Name
- Position
- Salary
- James Foster
- Chief Executive Officer and Chairman of the Board
- 650.80K
- Dr. Nigel McCracken
- Chief Operating Officer and Director
- 300.14K
- Jason Davis
- Chief Financial Officer
- 625.12K
- Evan Norton
- Independent Director
- 100.30K
- Yair Erez
- Independent Director
- 100.30K
- Nelson M. Haight
- Independent Director
- 100.30K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
